Novartis Sales Up 2.5% in 2012 Thanks to Rapid Growth in New Fields

Hiroyuki Mitani, President, Novartis Pharma Novartis Pharma posted sales of 323.4 billion yen, a 2.5% increase in the January-December period in 2012 in Japan compared to a year earlier, thanks to a large increase in sales of Lucentis (ranibizumab) for...read more